EMEA-002093-PIP02-17-M01

Table of contents

Key facts

Active substance
Calcifediol
Therapeutic area
Uro-nephrology
Decision number
P/0503/2020
PIP number
EMEA-002093-PIP02-17-M01
Pharmaceutical form(s)
  • Age-appropriate oral liquid dosage form
  • Prolonged-release capsule
Condition(s) / indication(s)
Treatment of secondary hyperparathyroidism (SHPT)
Route(s) of administration
Oral use
Contact for public enquiries
Vifor Fresenius Medical Care Renal Pharma France

E-mail: rayaldee_ra@viforpharma.com
Tel.  +41 5885 18000

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating